Former UK Prime Minister David Cameron Champions Rare Disease Research in Emotional Cleveland Speech
CLEVELAND — Former British Prime Minister David Cameron delivered a heartfelt keynote at the Harrington Discovery Institute’s 13th Annual Scientific Symposium, held at the Cleveland Museum of Natural History on Wednesday. Now serving as Chair of the Oxford-Harrington Rare Disease Centre (OHC) Advisory Council, Cameron shared his personal connection to medical research—a mission shaped by tragedy.
A Father’s Mission
Cameron’s advocacy for rare disease research began after his eldest son, Ivan, was diagnosed with Ohtahara Syndrome, a severe neurological disorder, in 2002. At the time, little was known about the condition. Ivan passed away at just six years old.
“You never forget holding your child in the hospital as they die,” Cameron said, his voice breaking. “It stays with you forever.”
That loss now fuels his work with the Oxford-Harrington Rare Disease Centre, a collaboration between the University of Oxford and the U.S.-based Harrington Discovery Institute. The center aims to fast-track treatments for rare diseases, which often lack research funding.
Breaking New Ground in Medicine
The numbers speak for themselves:
- 214 medicines in development
- 74 institutions supported worldwide
- 41 companies launched
- 15 pharmaceutical licenses secured
- 21 treatments currently in clinical trials
Cameron emphasized the urgency of funding scientific breakthroughs. “Even as Prime Minister, when budgets were tight, I protected medical research,” he said. “Governments must prioritize science—it saves lives.”
A Global Call to Action
The Oxford-Harrington Centre focuses on bridging gaps between academia and industry, ensuring promising discoveries reach patients faster. For Cameron, the work is deeply personal. “What we’re doing will change lives for families like mine,” he said. “After 24 years, the pain hasn’t faded—but neither has my determination.”
The symposium highlighted the institute’s broader mission: accelerating treatments for diseases that have long been overlooked. With rare conditions affecting nearly 1 in 10 people worldwide, Cameron’s message resonated far beyond the lecture hall.
— Reported by Nexio News
